Takeda Pharmaceutical's Interest & Investment Income rose 57278.79% to $570.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 33876.94%. This contributed to the annual value of $305.6 million for FY2025, which is 1540.12% down from last year.
According to the latest figures from Q4 2025, Takeda Pharmaceutical's Interest & Investment Income is $570.9 million, which was up 57278.79% from $1.4 billion recorded in Q3 2025.
In the past 5 years, Takeda Pharmaceutical's Interest & Investment Income registered a high of $1.4 billion during Q3 2025, and its lowest value of -$165.6 million during Q1 2022.
For the 5-year period, Takeda Pharmaceutical's Interest & Investment Income averaged around $290.7 million, with its median value being $236.2 million (2023).
In the last 5 years, Takeda Pharmaceutical's Interest & Investment Income surged by 114249.22% in 2021 and then tumbled by 13691.68% in 2022.
Quarter analysis of 5 years shows Takeda Pharmaceutical's Interest & Investment Income stood at $36.5 million in 2021, then soared by 709.05% to $295.0 million in 2022, then crashed by 69.5% to $90.0 million in 2023, then decreased by 5.7% to $84.9 million in 2024, then surged by 572.79% to $570.9 million in 2025.
Its last three reported values are $570.9 million in Q4 2025, $1.4 billion for Q3 2025, and $308.9 million during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value